AbbVie’s Allergan: FDA accepts sPMA for SKINVIVE by JUVEDERM

Allergan Aesthetics, an AbbVie (ABBV) company, announced that the U.S. FDA accepted for review the supplemental premarket approval application for SKINVIVE by JUVEDERM to reduce neck lines for the improvement of neck appearance. SKINVIVE by JUVEDERM is currently approved in the U.S. to improve skin smoothness of the cheeks in adults over the age of 21.